What ElleVet Sciences does

ElleVet Sciences is a veterinary health products company founded in 2016 and headquartered in South Portland, Maine, that develops and sells proprietary CBD+CBDA supplements for dogs, cats, and horses. Its core technology is a proprietary Complete Spectrum Hemp Oil containing a 50/50 blend of CBD and CBDA together with minor cannabinoids and terpenes, sourced from a hemp cultivar developed exclusively for the company and grown in Colorado. The product portfolio spans oils, soft chews, soft gels, paste, pellets, and dental sticks, with species-specific formulations (notably higher per-kg dosing for cats) addressing mobility, stress, skin health, neurological support, cognitive function, and oral health. The company's scientific differentiation rests on more than 40 clinical trials and over 20 peer-reviewed studies, including the first-ever canine CBD+CBDA trial at Cornell University (2017) and a first-of-its-kind feline mobility trial at the University of Utrecht (2025), with efficacy rates of 75% (dogs, joint discomfort), 71% (cats, mobility), 83% (dogs, stress), and 65% (dogs, skin).

ElleVet operates a dual go-to-market model combining direct-to-consumer e-commerce (ellevetsciences.com) with subscription pricing (25% off first order, 15% off recurring) and B2B wholesale to veterinary clinics nationwide, supported by a Vet Finder directory. Products are also distributed through retail partners across the United States, Canada, the United Kingdom, Germany, France, Ireland, Australia, and New Zealand. Revenue is generated via one-time product sales and recurring subscriptions, with veterinary clinic sales backed by an efficacy guarantee. The company holds the NASC Quality Seal and won the 2025 Pet Innovation Award for Dog Soft Chew CBD Product of the Year.

The company is privately held and founder-led, with Christian Kjaer (former IDEXX Laboratories senior executive) serving as Executive Chair and Cofounder and Dr. Joseph Wakshlag (Cornell Professor of Nutrition and Sports Medicine) as Chief Medical Officer. ElleVet has grown without disclosed external venture or institutional funding, scaling an 11-50 employee operation, multiple product lines, and manufacturing from a single South Portland facility. Its research partnerships with Cornell, University of Florida, and University of Utrecht form the basis of its evidence-based competitive positioning in the veterinary cannabinoid category.

Name

ElleVet Sciences

Legal name

ElleVet Sciences

Website

https://ellevetsciences.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

ElleVet Sciences is a privately held veterinary health company that develops and sells proprietary CBD+CBDA supplements for dogs, cats, and horses, distributed direct-to-consumer and through veterinary clinics and retail partners across North America, Europe, and Asia-Pacific.

Ownership category

akta.pro rank

Product category

Veterinary Pet Health Supplements

NAICS

Food (Health) Supplement Retailers (456191), Pet and Pet Supplies Retailers (45991)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

CBD/Hemp Wellness & Supplements Retail (CRANAHAC)

akta.pro secondary industries

CBD/Hemp Pet Products Retail (CRANAHAF), Species-Specific Supplements (Dog/Cat/Other Companion Species) (HLAMALAN), Specialty & Condition-Specific Nutraceuticals (e.g., Liver, Eye, Endocrine) (HLAMALAO), Calming & Behavioral Support Supplements (HLAMALAD)

Keywords

• Pet CBD supplements
• Veterinary hemp products
• Animal health supplements
• Pet wellness chews
• Equine feline canine CBD

Headquarters

HQ city

South Portland

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Direct Product Sales: ElleVet sells CBD + CBDA products for dogs, cats, and horses directly to pet owners through its e-commerce website. Products include chews, oils, soft gels, paste, and pellets at price points ranging from $20 to $249. Both one-time purchases and subscription options available.
2. Subscription Revenue: Recurring subscription model offering 25% off first order and 15% off all subsequent orders for pet owners. Subscriptions can be changed, paused, or cancelled anytime. Orders over $150 receive free standard shipping.
3. Veterinary Clinic Wholesale: Products sold wholesale to veterinary clinics across the US. Veterinarians recommend and distribute ElleVet products directly to pet owners through their practices. An efficacy guarantee backs products sold through veterinary channels.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Core offering

ElleVet Sciences manufactures and sells proprietary CBD + CBDA supplement products for dogs, cats, and horses, including oils, soft chews, soft gels, paste, pellets, and CBG dental sticks, formulated with a proprietary 50/50 CBD to CBDA ratio and a proprietary hemp cultivar. Products are sold direct-to-consumer through ellevetsciences.com on a one-time and subscription basis, and wholesale to veterinary clinics nationwide.

Product overview

ElleVet Sciences offers a comprehensive line of veterinarian-recommended hemp CBD + CBDA products for pets including dogs, cats, and horses. The company's proprietary Complete Spectrum Hemp Oil contains a 50/50 blend of CBD and CBDA and has been proven effective in multiple clinical trials. Products are available in multiple delivery formats: oils (for precise administration), soft chews (easy-to-give with added joint support for dogs), soft gels (odorless for picky pets), paste (for cats with dial-a-dose syringe), and pellets (for horses). The product portfolio addresses mobility/joint discomfort, stress/anxiety, skin health, neurological support, and cognitive function across multiple species. The company also offers a situational-use product (Calm & Comfort) and dental health product (CBG Dental Sticks) expanding beyond core CBD offerings.

Differentiator

Problem solved

Functional benefit

Brands

• The ElleVet Project: Charitable initiative (now inactive) that provided free veterinary care to pets of people with limited means. Assets acquired by The Street Dog Coalition.

Products and services

• Hemp CBD Chews for Dogs Soft chews formulated with proprietary CBD + CBDA for dogs, including glucosamine and chondroitin for added joint support. Available in small dog (under 40 lbs) and large dog (over 40 lbs) sizes; sold to pet owners direct and recommended by veterinarians.
• Hemp CBD Soft Gel Capsules for Dogs Odorless and flavorless soft gel capsules for dogs, available in four strengths (Small 5-19 lb, Medium 20-59 lb, Large 60-89 lb, Extra-Large 90-150 lb). Ideal for picky dogs and those with food sensitivities.
• Hemp CBD Oil for Dogs Original CBD + CBDA oil for dogs with 70mg/mL potency, available in 15mL, 30mL, and 60mL sizes for precise administration across dog weight ranges.
• Calm & Comfort Chews for Dogs Maximum strength situational-use CBD chews for dogs containing 46mg CBD + CBDA per chew, designed for high-stress situations such as fireworks, vet visits, and thunderstorms; provides relief in 1.5-2 hours.
• Hemp CBG Dental Sticks for Dogs Star-shaped dental sticks for dogs formulated with CBG (cannabigerol) for oral health support, with parsley and peppermint for fresh breath. Small sticks (40mg CBG) for dogs under 40 lbs, large sticks (60mg CBG) for dogs over 40 lbs; administered 2-3 sticks per week.
• Hemp CBD Chews for Cats Salmon-flavored soft chews formulated specifically for cats with proprietary CBD + CBDA for mobility, stress, and overall comfort support.
• Hemp CBD Oil for Cats CBD + CBDA oil formulated for cats with cat-specific administration instructions, as cats require higher amounts per kg than dogs due to different metabolism.
• Hemp CBD Paste for Cats (Feline Complete Paste) Chicken and pork flavored paste in an easy dial-a-dose syringe for cats. Contains 10mg cannabinoids per gram; each box contains two syringes with 300mg cannabinoids per syringe. Supports mobility, stress, and cognitive function.
• Hemp CBD Soft Gel Capsules for Cats Odorless and tasteless soft gel capsules for cats, ideal for picky felines and cats with food sensitivities.
• Hemp CBD Pellets for Horses Whole hemp pellets designed for horses with a 50/50 CBD and CBDA ratio. Supports mobility, calm, and focus; can be given at mealtimes or administered standalone.

Quantifiable outcome

• 75% of dogs showed improvement in joint discomfort in Cornell clinical trial
• +4 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Seven partnerships are on record, tiered core, minor and secondary.

• University of UtrechtcoreStrategic or Co-development Partner · 1 January 2025Conducted groundbreaking feline mobility clinical trial published in The Journal of Feline Medicine and Surgery. The double-blinded, placebo-controlled crossover study demonstrated 71% improvement in cats using ElleVet CBD + CBDA paste.
• Orange-Winged Amazon Parrots StudyminorStrategic or Co-development Partner · 1 January 2023Collaborative study published in February 2023 showing twice-daily oral administration of ElleVet's full spectrum hemp extract was well tolerated in parrots with favorable pharmacokinetic profile.
• University of Florida College of Veterinary MedicinesecondaryStrategic or Co-development Partner · 1 January 2022Conducted 2022 study demonstrating safety and efficacy of CBD + CBDA for neurological support in dogs. Showed 40% of dogs had 50% or greater reduction in neurological events over 12 weeks.
• The Street Dog CoalitionminorOthers · 1 January 2021The ElleVet Project (founded during COVID-19 pandemic to help pets of people with limited means) was acquired by The Street Dog Coalition. ElleVet Sciences is now a legacy sponsor providing free veterinary care to those in need across the United States.
• The ElleVet ProjectminorOthers · 1 January 2020Founded during COVID-19 pandemic by Amanda and Christian, ElleVet's founders, to provide free veterinary care to pets of people with limited means. Flew to California and spent summer 2020 giving free veterinary care. Subsequently formed as a registered 501(c)(3). Assets acquired by The Street Dog Coalition.
• University of Florida College of Veterinary MedicinecoreStrategic or Co-development Partner · 1 January 2019Long-term research partnership conducting pharmacokinetics and safety studies on dogs and cats. Led by Dr. Deabold, the university conducted the long-term safety and pharmacokinetic study showing ElleVet's product is safe for both species. Also conducted neurological studies in 2022.
• Cornell University College of Veterinary MedicinecoreStrategic or Co-development Partner · 1 January 2017Landmark partnership beginning in 2017 with Dr. Joseph Wakshlag leading the first-ever clinical trial on dogs with joint discomfort. Dr. Wakshlag conducted the pharmacokinetic study, the clinical trial, and continues to collaborate on ongoing research. This partnership produced the most downloaded paper from the publisher of all time and established the standards for cannabinoid use in pets.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• HolistaPet: HolistaPet sells CBD oils, treats, capsules, and topicals specifically formulated for pets across dogs and cats. Directly competes with ElleVet on D2C channels with similar subscription models, though with less clinical research backing.
• Pet Releaf: Pet Releaf produces CBD products for pets (dogs, cats, horses) using proprietary hemp strains, with a focus on organic and sustainably sourced ingredients. Direct competitor in the clinically-oriented pet CBD niche with overlapping product formats.
• Canna-Pet: Canna-Pet is one of the original and largest pet CBD brands offering hemp-derived CBD products for dogs and cats. Direct competitor to ElleVet in the veterinary-recommended pet CBD category, with overlapping product formats (oils, capsules, treats) and similar D2C + retail distribution.
• King Kanine: King Kanine manufactures CBD oils, treats, and topical products for pets with similar D2C distribution and veterinary positioning. Direct competitor in the premium pet CBD segment with overlapping product categories.
• Innovet Pet: Innovet Pet offers hemp-based CBD products for dogs, cats, and horses with emphasis on natural and veterinary-grade formulations. Comparable peer with similar species coverage and D2C positioning, competing directly in the same niche.

Broad incumbents

• Charlotte's Web: Charlotte's Web is the leading consumer CBD brand that has expanded into pet products. As a publicly traded incumbent with much larger scale, broader distribution, and a portfolio of human and pet products, it competes with ElleVet in pet CBD but lacks ElleVet's depth of veterinary clinical research.
• CBDfx: CBDfx offers a wide range of CBD products including a dedicated pet line. As a broad incumbent in the consumer CBD market, it competes in pet CBD but without ElleVet's veterinary endorsement network and clinical research moat.
• Zesty Paws: Zesty Paws is a leading pet supplement brand offering soft chews and functional products across mobility, skin, calming, and other categories. As a broader pet wellness incumbent, it competes indirectly with ElleVet in many of the same use cases (joint, stress, skin) but without CBD/cannabinoid formulations or veterinary channel focus.
• Medterra: Medterra is a CBD company with broad product lines including a pet-focused range. A broader incumbent with greater scale and retail distribution than ElleVet, though with less veterinary-channel focus and clinical research depth.

Emerging players

• VetCBD: VetCBD is a veterinarian-formulated CBD brand for pets available through licensed veterinarians. Closely overlaps with ElleVet's vet-channel GTM but with a smaller product portfolio and limited published clinical trials.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ellevet-sciences

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ElleVet Sciences